Intraoperative Radiation Therapy in Early Stage Breast Cancer

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

Single arm study to assess the effectiveness of single dose intraoperative radiation therapy in patient with in situ and early stage breast cancer.

Key facts

Study ID

NCT02266602

Run by

Benaroya Research Institute

People needed

500

Starts

2012-02-01

Expected to finish

2018-07-31

Last updated by the study team

2019-04-26

Who can join

Age: 45 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• General Inclusion Criteria
• Age ≥ 45 years.
• Clinical stage Tis, T1, T2 (≤ 3cm), N0, M0 (AJCC Classification).
• Invasive ductal or lobular carcinoma, DCIS and/ or pleomorphic lobular carcinoma in situ.

You may not qualify if…

• Scleroderma, systemic sclerosis and active lupus.
• Participation in an investigational drug or device study.
• Previous ipsilateral radiation to the thorax or breast.
• Multifocal breast cancer.
• Pregnant patients.
• Patient not competent to provide informed consent.
• Neoadjuvant systemic therapy.
• Lymphovascular invasion on biopsy pathology

Where it is running

• Virginia Mason Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.